RASSF1A downregulates AREG by activation of Hippo pathway RASSF1A-mediated regulation of amphiregulin via the Hippo pathway in hepatocellular carcinoma
نویسندگان
چکیده
Ras association domain family 1 isoform A (RASSF1A) is a tumor suppressor and the methylation thereof is known to be involved in many human cancers including hepatocellular carcinoma (HCC). RASSF1A has been shown to suppress tumors via activation of components of the Hippo tumor suppressor pathway, including mammalian STE20-like kinase (MST). Amphiregulin (AREG), a target gene for Yes-associated protein (YAP), is a known oncogenic component of the Hippo pathway; however, the tumor suppressive effect of RASSF1A on AREG in regards to regulation of the Hippo pathway remains unclear in HCC. In this study, overexpression of RASSF1A in HCC cells (Hep3B, SK-Hep1, and PLC/PRF/5), which lack functional RASSF1A, significantly inhibited cell proliferation and induced apoptosis by activating the Hippo pathway. Consequently, overexpression of RASSF1A inhibited the oncogenic functions of YAP, leading to a significant reduction in AREG secretion via regulation of the Hippo pathway. In human study, greater expression of RASSF1A was observed in chronic hepatitis (CH)/cirrhosis than in HCC, whereas expression of YAP and AREG was higher in 81% and 86% of HCC than corresponding CH/cirrhosis, respectively. Furthermore, a gradual decrease in RASSF1A protein expression was detected as multistep hepatocarcinogenesis progressed from CH/cirrhosis, dysplastic nodules (DNs), toward HCCs, while the protein expression of YAP and AREG gradually increased. These findings give evidence to the regulation of YAP and AREG (YAP signature) by RASSF1A in human multistep hepatocarcinogenesis. In conclusion, our results suggest that RASSF1A might play a crucial role in HCC suppression by regulating AREG expression via activation of the Hippo tumor suppressor pathway, leading to inactivation of oncogenic YAP. on June 27, 2017. © 2013 American Association for Cancer Research. mcr.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on April 17, 2013; DOI: 10.1158/1541-7786.MCR-12-0665
منابع مشابه
RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma.
Ras association domain family 1 isoform A (RASSF1A) is a tumor suppressor that is methylated in many human cancers, including hepatocellular carcinoma (HCC). RASSF1A has been shown to suppress tumors via activation of the Hippo tumor suppressor pathway, including mammalian STE20-like kinase (MST). Amphiregulin (AREG), a target gene for Yes-associated protein (YAP), is a known oncogenic componen...
متن کاملRheb may complex with RASSF1A to coordinate Hippo and TOR signaling
The TOR pathway is a vital component of cellular homeostasis that controls the synthesis of proteins, nucleic acids and lipids. Its core is the TOR kinase. Activation of the TOR pathway suppresses autophagy, which plays a vital but complex role in tumorigenesis. The TOR pathway is regulated by activation of the Ras-related protein Rheb, which can bind mTOR. The Hippo pathway is a major growth c...
متن کاملInvestigating the mRNA expression levels of Hippo pathway in adenoma polyps
Background Neoplastic adenomatous polyps generating from the epithelial cells are considered benign tumors. Adenomatous polyps are common in western countries and it can take seven to 10 or more years for an adenoma to evolve into cancer. The Hippo signaling pathway, also known as the Salvador-Warts-Hippo (SWH) pathway, is a signaling pathway that controls organ size in animals through the r...
متن کاملAlternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion
Tumor progression to invasive carcinoma is associated with activation of SRC family kinase (SRC, YES, FYN) activity and loss of cellular cohesion. The hippo pathway-regulated cofactor YAP1 supports the tumorigenicity of RAS mutations but requires both inactivation of hippo signaling and YES-mediated phosphorylation of YAP1 for oncogenic activity. Exactly how SRC kinases are activated and hippo ...
متن کاملAnalysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1.
The tumor suppressor gene RASSF1A is epigenetically silenced in most human cancers. As a binding partner of the kinases MST1 and MST2, the mammalian orthologs of the Drosophila Hippo kinase, RASSF1A is a potential regulator of the Hippo tumor suppressor pathway. RASSF1A shares these properties with the scaffold protein SAV1. The role of this pathway in human cancer has remained enigmatic inasmu...
متن کامل